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Abstract 8 
 9 
We demonstrate the feasibility of a label-free electrochemical method to detect the kinetics of phosphorylation and 10 
dephosphorylation of surface-attached peptides catalyzed by kinase and phosphatase, respectively. The peptides 11 
with a sequence specific to c-Src tyrosine kinase and protein tyrosine phosphatase 1B (PTP1B) were first validated 12 
with ELISA-based protein tyrosine kinase assay and then functionalized at vertically aligned carbon nanofiber 13 
(VACNF) nanoelectrode arrays (NEAs). Real-time electrochemical impedance spectroscopy (REIS) measurements 14 
showed reversible impedance changes upon addition of c-Src kinase and PTP1B phosphatase. Only small and 15 
unreliable impedance variation was observed during the peptide phosphorylation, but a large and fast impedance 16 
decrease was observed during the peptide dephosphorylation at a series of PTP1B concentrations. The REIS data of 17 
dephosphorylation displayed a well-defined exponential decay following the Michaelis-Menten heterogeneous 18 
enzymatic model with a consistent specific constant kcat/Km = (2.130.09)x10
7 M-1s-1. This electrochemical method 19 
can be potentially used as a label-free method for profiling enzyme activities in fast reactions. 20 
 21 
Keywords: 22 
real-time electrochemical impedance spectroscopy 23 
phosphorylation 24 
dephosphorylation 25 
2 
 
heterogeneous enzyme kinetics 1 
vertically aligned carbon nanofibers 2 
nanoelectrode array 3 
c-Src tyrosine kinase 4 
protein tyrosine phosphatase 1B 5 
 6 
Abbreviations: real-time electrochemical impedance measurements (REIS), nanoelectrode array (NEA), 7 
vertically aligned carbon nanofiber (VACNF), protein tyrosine phosphatase 1B (PTP1B), APTES, sulfo-NHS, sulfo-8 
EMCS, HRP, CNF, FESEM, ELISA, EGFR 9 
* Corresponding author at: Department of Chemistry, Kansas State University, Manhattan, KS 66506, USA. 10 
Tel.: +1 785 532 0955; fax: +1 785 532 6666. 11 
E-mail address: junli@k-state.edu (J. Li). 12 
 13 
1. Introduction 14 
 15 
Protein kinases and phosphatases have been under intense study for their roles in fundamental 16 
biochemical processes and signal transduction pathways [1, 2]. Recently, they have become attractive 17 
targets for therapeutic drug discovery [3-6]. Kinase catalyzes the transfer of the phosphate group at  -18 
position of ATP to specific protein/peptide substrates; this process is referred to as phosphorylation. 19 
Phosphatase catalyzes the reverse process, removing the phosphate group from the phosphorylated 20 
substrates; this process is called dephosphorylation. Phosphorylation and dephosphorylation are reversible 21 
dynamic processes, which are important regulatory mechanisms in both prokaryotic and eukaryotic 22 
organisms [7]. 23 
The most direct way of detecting phosphorylation is to measure the radioactive
 32
P transferred 24 
from -32P-ATP to the amino acid residues on the protein substrates [7-9]. Other major methods include 25 
fluorescence labeling, chemiluminescence, electroluminescence [10-15], mass spectroscopy [16, 17], and 26 
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surface plasmon resonance [18-22]. Recently, electrochemical detections of kinase activities have been 1 
reported using redox-labeled cosubstrate adenosine 5’-[-ferrocene] triphosphate (Fc-ATP) [23] or 2 
binding of gold nanoparticles to thiol-modified adenosine 5’-[-thio] triphosphate (ATP-S) [24]. These 3 
methods either require costly reagent (chemically labeled ATP or phosphor-specific antibodies) or are 4 
limited by the lack of miniaturization and/or multiplexing capability. In this study, we explore the 5 
feasibility of a label-free rapid electrochemical method which could be implemented on a multiplex chip. 6 
Reversible phosphorylation and dephosphorylation under the heterogeneous catalyses of protein tyrosine 7 
kinase c-Src and protein tyrosine phosphatase 1B (PTP1B), respectively, have been detected and 8 
quantified. 9 
C-Src kinase is a cytoplasmic protein belonging to a family of non-receptor protein tyrosine 10 
kinases that catalyze the phosphorylation to specific tyrosine residues of the substrates. In normal cells, c-11 
Src kinase participates in proliferation, maintenance of normal intercellular contacts, and cell motility 12 
[25]. Clinical studies have shown that increased activity of c-Src kinase is correlated to cancer 13 
progression. Also, high expression levels of c-Src kinase are found in human tumors corresponding to 14 
lung, breast, pancreatic, colon, and prostate cancers [26]. Small inhibitors against c-Src kinase have been 15 
developed as anti-cancer drugs [27]. PTP1B is a non-transmembrane protein that dephosphorylates 16 
phosphotyrosine residues on protein substrates. It is known to inhibit insulin and leptin signaling, and has 17 
been an attractive therapeutic target for diabetes, obesity [28], and anti-tumor drugs [29, 30]. 18 
The label-free electrochemical method is illustrated in Fig. 1 in which peptides are immobilized 19 
on an electrode surface. Phosphorylation of the peptides by kinase introduces phosphate groups and 20 
negative charges to the electrode surface. Reversely, dephosphorylation of the phosphorylated substrates 21 
by phosphatase removes the negatively charged phosphate groups from the peptides. The changes in 22 
charge density and/or conformation of the peptides accompanying these reactions may induce changes in 23 
electrochemical impedance |Z|. This method may be applied on multiplex electrode arrays on a microchip 24 
enabling simultaneously profiling of the activities of multiple kinases and phosphatases.  25 
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 2 
 3 
Fig. 1. Schematic of the principles of label-free electrochemical impedance detection of enzymatic activities of 4 
kinase and phosphatase. (A) The reversible phosphorylation and dephosphorylation of surface-attached peptide 5 
substrates catalyzed by kinase and phosphatase, respectively. (B) Schematic of real-time electrochemical impedance 6 
spectroscopy (|Z| vs. time) during the enzymatic phosphorylation and dephosphorylation reactions. 7 
 8 
Particularly, we apply this method on a nanoelectrode array (NEA) fabricated with vertically 9 
aligned carbon nanofibers (VACNFs) in SiO2 matrix with only the very end exposed [31, 32]. As 10 
demonstrated in previous studies [31, 32], the carbon nanofiber (CNF) tip can be covalently attached with 11 
biomolecules. The electrochemical properties of the VACNF NEAs are highly sensitive to the structure of 12 
the biomolecules at the highly miniaturized electrode surface. Conceptually, phosphorylation and 13 
dephosphorylation of the peptide substrates attached to the VACNF NEA could affect the molecular 14 
packing and generate notable impedance changes. However, the kinetic study of the heterogeneous 15 
enzymatic reaction at NEAs has not been reported. Here we demonstrate that the reversible impedance 16 
changes associated with phosphorylation and dephosphorylation of the peptides covalently attached to the 17 
VACNF NEA can be detected with label-free real-time impedance spectroscopy (REIS). The impedance 18 
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change was found to strongly depend on enzyme’s specificity constant. The rate of dephosphorylation 1 
catalyzed by PTP1B was found much higher than that of c-Src phosphorylation to the same peptide 2 
substrate attached at the VACNF NEA. The PTP1B dephosphorylation process showed a well-defined 3 
kinetic curve, which can be quantitatively analyzed with a heterogeneous Michaelis-Menten enzymatic 4 
model. 5 
 6 
2. Materials and methods 7 
 8 
2.1 Materials 9 
 10 
Tyrosine kinase buffer (500 mM HEPES, pH 7.4, 200 mM MgCl2, 1 mM MnCl2, and 2 mM 11 
Na3VO4) was purchased from Sigma-Aldrich (Saint Louis, Missouri). Active c-Src kinase protein (N-12 
terminal 6His-tagged recombinant human c-Src, molecular weight 61.7 kDa) was purchased from 13 
Milipore (Billerica, MA). Peptide substrate of c-Src kinase (Biotin-AEEEIYGEFEAKKKKC) was 14 
synthesized by AnaSpec, Inc. (Fremont, CA). The Protein Tyrosine Kinase Assay Kit of an enzyme-15 
linked immunosorbent assay (ELISA), including adenosine-5’-triphosphate (ATP), epidermal growth 16 
factor receptor (glycosylated EGFR, molecular weight 170 kDa) and monoclonal anti-phosphotyrosine-17 
peroxidase conjugate was purchased from Sigma-Aldrich (Saint Louis, Missouri). PTP1B (residues 1-18 
322, molecular weight 37.4 kDa) and phosphatase buffer (50 mM HEPES, pH 7.2, 1 mM EDTA, 1 mM 19 
DTT, and 0.05% NP-40) were purchased from Enzo Life Sciences, Inc. (Plymouth Meeting, PA). 20 
Chemicals (3-aminopropyl)triethoxysilane (APTES), 2-[2-(2-methoxyethoxy)ethoxy]acetic acid, N-ethyl-21 
N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), hydroxy-2,5-dioxopyrrolidine-3-sulfonic 22 
acid sodium salt (sulfo-NHS), 9-fluorenylmethyl N-(6-aminohexyl) carbamate hydrobromide, and 23 
piperidine were purchased from Sigma-Aldrich. N-[-Maleimidocaproyloxy]sulfosuccinimide ester 24 
(sulfo-EMCS) was purchased from Thermo Fisher Scientific Inc. (Waltham, MA). Carboxylated latex 25 
beads derivatized with streptavidin and impregnated with yellow-green fluorescent dyes (in wt 1% 26 
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suspension, average diameter of 50 nm, with excitation wavelength at 470 nm and emission wavelength at 1 
505 nm) were purchased from Sigma-Aldrich (Saint Louis, Missouri). 2 
 3 
2.2 Fabrication of VACNF NEAs 4 
 5 
The NEAs were fabricated by encapsulating VACNFs in a SiO2 matrix on a silicon chip using the 6 
method described in the previous papers [31, 32]. Briefly, VACNFs of the average length of ~5 m were 7 
grown on Cr-coated Si substrate using a DC-biased plasma enhanced chemical vapor deposition 8 
(PECVD). A thin nickel film of ~22 nm was used as a catalyst to promote carbon nanofiber (CNF) 9 
growth. The electric field helped to align the CNF vertically on the substrate surface. Dielectric SiO2 was 10 
deposited using chemical vapor deposition (CVD) from vapor-phase precursor tetraethylorthosilicate 11 
(TEOS) to fully encapsulate the bottom Cr metal contact layer and each individual CNFs. Mechanical 12 
polishing was applied using 0.3 m alumina slurry to produce a flat surface. Reactive ion etching (RIE) 13 
with a mixture of CHF3 and O2 gases was then performed to selectively etch away desired amount of SiO2 14 
and expose some of the CNF tips. A typical VACNF NEA for electrochemical measurements consists of 15 
randomly distributed CNF tips with an average CNF diameter of ~200 - 300 nm and an average spacing 16 
over ~1 m (~1 - 10 x 106 CNFs/cm2), as shown in Fig. S1 (Supplementary Information). A length of ~50 17 
- 300 nm at the CNF tips were exposed at the SiO2 surface, which can be controlled by varying the RIE 18 
time to selectively remove SiO2.  19 
 20 
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Fig. 2. The scheme for functionalizing peptide to CNF tips. (A) Schematic drawing of VACNFs embedded in SiO2 3 
matrix; (B) a biotinylated peptide substrate specific to c-Src kinase is covalently attached to the CNF tip through 4 
coupling the thiol group in the cysteine residue with a maleimide group of a linker molecule.  5 
 6 
2.3 Electrode pre-conditioning 7 
8 
 
 1 
Before each use, VACNF NEAs were further polished with 0.05 µm -alumina slurry (Buehler) 2 
on napless polishing cloth for 5 min, followed by rinsing with deionized water. The polishing and rinsing 3 
procedures were repeated once followed by sonication in deionized water for 15 min. The VACNF NEAs 4 
were then electrochemically activated by etching in 1.0 M NaOH solution using four cycles of cyclic 5 
voltammetry (CV) with a potential range of -0.10 V to 1.20 V (vs. Ag/AgCl (3 M KCl)) at a scan rate of 6 
50 mV∙s-1. Electrodes were rinsed with deionized water and stored in a Petri dish before use. 7 
 8 
2.4 Functionalization and passivation of the VACNF NEA chip 9 
 10 
To reduce nonspecific adsorption, the SiO2 surface of VACNF NEAs was first passivated with 11 
protective moieties containing ethylene glycol, as described in our previous report [33, 34]. The chip was 12 
immersed in an 8 g L
-1
 solution of APTES in ethanol for 20 min to produce a primary amine derivatized 13 
surface. The chip was treated with 50 L solution of 0.1 mM of 2-[2-(2-methoxyethoxy)ethoxy]acetic 14 
acid, 100 g L
-1
 of EDC, and 50 g L
-1
 of sulfo-NHS, and incubated at room temperature for 2 hours. The 15 
carboxylic acid group of 2-[2-(2-methoxyethoxy)ethoxy]acetic acid formed an amide bond with the 16 
amino function on the chip surface, leaving ethylene glycol moiety covering the surface. The molecules at 17 
the CNF tips were then removed by electrochemical etching at 1.2 V (vs. Ag/AgCl (3 M KCl)) for 20 sec. 18 
in 1.0 M NaOH solution. This process regenerated clean CNF tips which contain abundant carboxylic 19 
acid functional groups.  20 
The scheme for functionalization of the peptide to a CNF tip is illustrated in Fig. 2. A cysteine 21 
was added to the carboxyl terminus of the original c-Src kinase peptide substrate 22 
(AEEEIYGEFEAKKKK), so that the thiol group of the cysteine can be conjugated to the CNF through a 23 
maleimide linker. In addition, a biotin was added to the N-terminus for the binding study described below. 24 
A 50 L solution of 0.1 mM N-Fmoc-1,6-diaminohexane hydrobromide, 100 g L-1 of EDC, and 50 g L-1 25 
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of sulfo-NHS were applied to the chip and incubated at room temperature for 2 hours. The unprotected 1 
amine function of the diaminohexane was coupled with the carboxylic acid group of CNF. The Fmoc 2 
protecting group was then removed by incubating in 10% piperidine in DMF at room temperature for 15 3 
min followed by rinsing with DMF. The deprotection procedure was repeated once followed by rinsing 4 
with deionized water. A 1.0 mM sulfo-EMCS linker was then applied to the chip and incubated at room 5 
temperature for 30 min, allowing the deprotected amine group to react with sulfo-EMCS. Then 50 L 6 
solution of 2 M biotinylated c-Src peptide substrate with the cysteine at C-terminus (i.e. biotin-7 
AEEEIYGEFEAKKKKC) was applied to the chip and incubated at room temperature for 2 hours. Hence, 8 
the peptide substrate was immobilized on the chip through the Michael addition reaction between the thiol 9 
group of cysteine residue and the maleimide moiety of CNFs. 10 
To verify the coupling of the peptides to CNFs, streptavidin-derivatized latex beads (50 nm in 11 
diameter) in phosphate buffered saline solution (PBS, pH 7.4) with 0.005% Tween 20 were applied to the 12 
chip followed by extensive washing. The impregnated yellow-green fluorescent dyes in the beads were 13 
revealed under a fluorescence optical microscope (Axioskop II, Carl Zeiss) as shown in Fig. S2 14 
(Supplementary Information). The attachment of the beads at the CNF tips through the specific biotin-15 
streptavidin binding was further verified with a field-emission scanning electron microscope (FESEM) 16 
(Leo 1550, Zeiss) as shown in Fig. 3. 17 
 18 
2.5 ELISA assays to validate the activities of c-Src kinase and PTP1B 19 
 20 
The detailed protocols for ELISA-based protein tyrosine kinase assay using a commercial kit are 21 
illustrated in Fig. S3. The peptide substrates at a concentration of 0.125 mg∙mL-1 in PBS were added to 22 
wells of a 96-well plate, and incubated overnight at 37 ºC. The peptide solution was then removed and the 23 
plate was dried at 37 ºC for 2 hours. A volume of 110 L tyrosine kinase buffer (with the composition 24 
given in “2.1 Materials”) containing active c-Src kinase and ATP was added to each well for reactions. C-25 
10 
 
Src kinase concentration in the mixed solution was varied from 0.18 nM to 5.9 nM (corresponding to 1.25 1 
– 40 ng of c-Src in 110 L of solution) and the ATP concentration was fixed at 0.30 mM. After 2 
incubation and washing, a solution of phosphotyrosine monoclonal antibody linked with horseradish 3 
peroxidase (HRP) was applied to specifically bind with phosphotyrosine residues of the peptide 4 
substrates. HRP then catalyzed the conversion of supplied colorless o-phenylenediamine (OPD) into 5 
brown-color 2,3-diaminophenazine (DAP) which presents a peak absorbance at 490 nm. The absorbance 6 
at 490 nm in each well was read by a microplate reader (model EL307C, BioTek). 7 
 8 
 9 
 10 
Fig. 3. Verification of the coupling of the peptide and CNF using streptavidin-labeled fluorescent beads. (A) A 11 
schematic drawing shows fluorescent beads selectively bound to the surface-functionalized peptide through biotin-12 
streptavidin interaction; (B and C): FESEM images at top and 45 perspective views show that many 50-nm 13 
diameter beads were attached to the exposed CNF tips (indicated by solid arrows) while only a few beads 14 
nonspecifically bound to the SiO2 surface (as indicated by dashed arrows). The scale bars in B and C are 100 nm. 15 
 16 
The dephosphorylation activity of PTP1B was validated by measuring the amount of remaining 17 
phosphotyrosine after incubation using the same ELISA assay kit. The 96-well plate was first coated with 18 
the biotinylated peptide substrates. The solution of 5.9 nM c-Src kinase and 0.3 mM ATP in tyrosine 19 
11 
 
kinase buffer was added to each well and incubated at room temperature for one hour to ensure that 1 
tyrosine residues on all peptides were phosphorylated. After washing with PBS-Tween 20 buffer and 2 
drying for 2 hours at 37 °C, PTP1B in 110 L phosphatase buffer was added to the well and incubated at 3 
room temperature for 30 min. for dephosphorylation. The PTP1B concentration was varied from 0.076 4 
nM to 2.4 nM. In some experiments, the phosphatase buffer was modified by removing the detergent NP-5 
40 to get more reliable electrochemical measurements. The wells were washed thoroughly with PBS-6 
Tween 20 buffer and dried. Then a similar ELISA procedure as described above was applied. The 7 
absorbance at 490 nm, which indicates the amount of remaining phosphotyrosine in each well, was read 8 
with the BioTek microplate reader. 9 
 10 
2.6 Electrochemical measurements 11 
 12 
All electrochemical measurements were performed in a TEFLON cell with a total volume of 13 
~120 L sealed against the VACNF NEA chip with a 3-mm i.d. O-ring. The experiment was controlled 14 
by a potentiostat (PARSTAT 2273, Princeton Applied Research Corporation) using a three-electrode 15 
setup (working electrode: VACNF NEA; counter electrode: a coiled platinum wire; and quasi-reference 16 
electrode: an Ag wire). The real-time electrochemical impedance spectroscopy (REIS) was performed at 17 
the open circuit potential with a 20 mV rms AC voltage at fixed frequency of 1000 Hz. 18 
 19 
3. Results and Discussion 20 
 21 
3.1 Characterization of peptide functionalization at CNF tips 22 
 23 
Functionalization of the peptide to the carboxylic groups at the CNF tip involves three steps 24 
illustrated in Fig. 2B. A biotinylated peptide substrate specific to c-Src kinase was covalently attached to 25 
12 
 
CNFs through coupling of the thiol group of the cysteine residue in the peptide with the maleimide group 1 
at the end of the linker molecule. The major part of the peptide sequence (i.e. AEEEIYGEFEAKKK, the 2 
optimal peptide substrate for c-Src kinase) was selected by screening a combinatorial peptide library and 3 
reported to undergo in vitro phosphorylation by c-Src kinase with very high efficiency [35]. As illustrated 4 
in Fig. 3A, a biotin was added to the distal end (i.e. N-terminus) of the peptide substrate in order to verify 5 
its functionalization to the exposed CNF tip through specific binding with streptavidin-derivatized 6 
fluorescent latex beads. Clear isolated fluorescent spots were observed under an optical microscope as 7 
shown in Fig. S2, attributed to the clusters of latex beads attached to CNF tips. In addition, FESEM 8 
images in Figs. 3B and 3C directly showed that many beads with ~50 nm diameter were attached to the 9 
exposed CNF tips (indicated by solid arrows), while only a few beads bound to the SiO2 surface ( 10 
indicated by dashed arrows). Due to charging effects, it was difficult to obtain FESEM images of 11 
nonconductive latex beads at higher resolution. For better graphical presentation, images taken from 12 
CNFs with the diameter larger than the average were shown. Interestingly, the beads bind not only to the 13 
very end of the tip but also to the exposed sidewalls. This is consistent with the presence of many broken 14 
graphitic edges along the sidewall as a result of the unique microstructure of CNFs, which consists of a 15 
stack of conical graphitic structures as illustrated in Fig. 2A, instead of concentric seamless tubes [36]. It 16 
is convincing that peptide substrates are covalently attached to the CNF tip. 17 
 18 
3.2 Validation of the enzymatic activities using the ELISA assay 19 
 20 
First, an ELISA assay using the commercial Protein Tyrosine Kinase Assay Kit was adapted to 21 
validate the enzymatic activity of c-Src kinase on the designed biotinylated peptide substrate. The detailed 22 
procedure is illustrated in Fig. S3. The absorbance at 490 nm was plotted vs. the quantity of kinase in Fig. 23 
4A. Clearly, the concentration of produced phosphotyrosine was proportional to that of c-Src kinase in the 24 
range from 0.18 nM to 5.9 nM (1.25 - 40 ng in 110 L of solution). There was no difference in 25 
absorbance for the peptide substrate with and without biotin (not shown), which confirms that 26 
13 
 
biotinylation does not affect the properties of the peptide. A negative control experiment was performed 1 
using another kinase, Epidermal Growth Factor Receptor (EGFR), which showed very low absorbance 2 
(data not shown). These studies validated that the designed peptide substrate (i.e. biotin-3 
AEEEIYGEFEAKKKC) is highly specific to c-Src kinase. 4 
 5 
 6 
 7 
Fig. 4. Validation of enzymatic activity with ELISA assay. (A) Phosphorylation of the biotinylated peptide (biotin-8 
AEEEIYGEFEAKKKC) by c-Src kinase measured with an ELISA assay following the procedure described in Fig. 9 
S3. The absorbance at 490 nm reflects the amount of phosphotyrosine, which is clearly proportional to the 10 
concentration of c-Src kinase from 0.18 nM to 5.9 nM (i.e. 1.25 - 40 ng in 110 L solution). The concentration of 11 
ATP in all reactions was fixed at 0.30 mM. (B) Dephosphorylation by PTP1B phosphatase measured with the same 12 
ELISA assay. The tyrosine residue in the biotinylated peptide was first phosphorylated by prolonged incubation in 13 
5.9 nM c-Src kinase. PTP1B at concentrations from 0.076 nM to 2.4 nM (i.e. 0.31 - 10 ng in 110 L solution) were 14 
14 
 
then added to remove the phosphate group from phosphotyrosine, and caused a decrease in the absorbance at 490 1 
nm.  2 
 3 
The activity of PTP1B on the same biotinylated peptide substrates was also validated with the 4 
same ELISA assay. The peptide coated in the wellplate was first incubated in a solution of 5.9 nM c-Src 5 
kinase and 0.3 mM ATP at room temperature for one hour to ensure that all tyrosine residues on the 6 
peptides were phosphorylated. After washing and drying, solutions containing 0.31 – 10 ng of PTP1B in 7 
110 L phosphatase buffer (i.e. 0.076 nM to 2.4 nM) were added to the wells and incubated at room 8 
temperature for 30 min and then followed by a similar ELISA procedure as above. The absorbance at 490 9 
nm was plotted in Fig. 4B vs. the quantity of PTP1B. The absorbance, which is proportional to the 10 
concentration of remaining phosphotyrosine, dropped from ~0.60 to 0.12 with only 0.5 ng (0.12 nM) 11 
PTP1B. In the kinase measurements, the absorbance only increased by 0.45 even at the highest c-Src 12 
kinase concentration (5.9 nM). Clearly, the catalytic efficiency of PTP1B is higher than that of c-Src 13 
kinase. 14 
 15 
3.3 Real-time electrochemical impedance (REIS) measurements 16 
 17 
Generally, there are two mechanisms for the electrochemical impedance measurements. The more 18 
common one employs redox mediators, such as an equimolar mixture of [Fe(CN)6]
3-
/[Fe(CN)6]
4-
 couple, 19 
to probe Faradaic impedance associated with the electron transfer resistance Rct in the equivalent circuit. 20 
The changes in the film thickness and packing density will affect the accessibility of the redox mediators 21 
to the electrode surface and the amplitude of Rct [37]. In the other mechanism, capacitive currents are 22 
measured without using redox species. These currents are mainly due to charging/discharging the 23 
electrical double layer at the electrolyte-electrode interface (i.e. Cdl in the equivalent circuit), which are 24 
also sensitive to the film packing and charge density on the electrode surface.  25 
15 
 
However, we found that the mediator mechanism was not applicable in this study. The activity of 1 
c-Src kinase was significantly suppressed when 1.0 mM of redox couple [Fe(CN)6]
3-
/[Fe(CN)6]
4-
 was 2 
added, as shown in the ELISA measurements in Fig. S4. As a result, our electrochemical impedance 3 
measurements were performed using the mediator-free mechanism. The detergent NP-40 in the 4 
commercial phosphatase buffer solution was also found not suitable for electrochemical measurements 5 
since it tended to induce bubbles at the electrode surface, leading to large noises. Thus the buffer 6 
composition for electrochemical measurements was modified and validated with the ELISA as shown in 7 
Figs. S4 and S5. The phosphorylation and dephosphorylation reactions only took a few minutes, which 8 
can be captured by REIS at a fixed frequency of 1000 Hz. 9 
Fig. 5 shows the REIS of a peptide-functionalized VACNF NEA upon adding 20 L c-Src 10 
kinase or PTP1B phosphatase, respectively, into 90 L of corresponding buffer solutions. Only small a 11 
change (<0.5%) in the total impedance value |Z| was observed with the final c-Src kinase concentration as 12 
high as 5.9 nM. The change was superimposed on the step-like jump due to disturbance to the solution, as 13 
shown in Fig. 5A. The impedance change was slow and unreliable. After the peptide at the VACNF NEA 14 
was fully phosphorylated after 1-hour incubation, the buffer was replaced with 90 L modified 15 
phosphatase buffer. The dephosphorylation reaction was monitored with REIS as shown in Fig. 5B. A 16 
stable |Z| at ~18,175 Ω was observed at the beginning. A sharp decrease in |Z| by ~1,150 Ω (~6.3%) was 17 
observed over the ~100 s period after adding 20 L PTP1B (to the final concentration of 2.4 nM). The 18 
experiments were repeated, and the results indicated that the peptide attached to the VACNF NEA could 19 
be reversibly phosphorylated and dephosphorylated by switching the enzymes and corresponding buffers. 20 
The impedance change corresponding to the dephosphorylation by PTP1B was consistently larger than 21 
that of the phosphorylation by c-Src kinase. This was likely due to the difference in the enzyme activities. 22 
Consistent with the ELISA assay, the REIS measurements for negative control using EGFR did not show 23 
clear kinetic profiles. 24 
 25 
16 
 
 1 
 2 
Fig. 5. Real-time electrochemical impedance measurements (|Z| vs. time) of peptide-functionalized VACNF NEAs. 3 
(A) Upon addition of 20 L c-Src kinase (at 100 second) to 90 L kinase buffer (i.e. 5.9 nM kinase and 0.30 mM 4 
ATP in the final solution), and (B) upon addition of 20 L PTP1B (at 73 second) to 90 L phosphatase buffer (2.4 5 
nM final concentration). The impedance value |Z| varied slowly after c-Src kinase was added, but decreased rapidly 6 
after PTP1B was added. 7 
 8 
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 2 
Fig. 6. Analyses of the enzymatic kinetics of the dephosphorylation process. (A) The real-time impedance data (as 3 
shown in Fig. 5B) at a peptide-functionalized VACNF NEA after adding 2.4 nM PTP1B (10.0 ng in 110 L 4 
solution) was normalized and  fit with an exponential function |Z|/|Z0| = 0.944∙exp (-t/19.1). (B) The plot of –5 
d(|Z||Z0|)/dt vs. |Z|/|Z0| fit by a straight line with a slope of 0.0522 s
-1
. 6 
 7 
3.4 Enzyme kinetics analysis 8 
 9 
The fast kinetics and the notable impedance change during dephosphorylation by PTP1B made it 10 
possible for quantitative analysis of enzyme activity based on the REIS results. The raw REIS data in Fig. 11 
5B after addition of PTP1B was extracted and modified in three steps: (1) a linear baseline drift (almost a 12 
18 
 
constant at ~17,000 Ω) was subtracted; (2) the subtracted |Z| value was normalized to |Z0|, the value right 1 
before adding PTP1B; and (3) the time at PTP1B addition was reset to zero. The modified curve (Fig. 6A) 2 
was then nicely fit with an exponential decay with |Z|/|Z0| = 0.944∙exp(-t/19.1). This kinetic data can be 3 
well described by a heterogeneous enzymatic model modified from Michaelis-Menten kinetics [38] as 4 
below: 5 
 6 
(1) 7 
 8 
where E, Ss, ESs, Ps and P represent the enzyme (PTP1B), the surface-bound phosphorylated peptide 9 
substrate, the enzyme-substrate complex on the electrode surface, the product of dephosphorylated 10 
peptide substrate on the electrode surface, and the product of cleaved phosphate, respectively. The 11 
reaction rate can be defined as 12 
 13 
(2) 14 
 15 
where kcat is the dissociation rate constant, Km = (kcat+k-1)/k1 is the Michaelis-Menten constant, and ΓSs, ΓPs 16 
represent the surface densities of phosphorylated and dephosphorylated peptide substrates, respectively. 17 
At low enzyme concentrations where [E0] << Km, an approximate relationship can be obtained as  18 
 19 
(3) 20 
 21 
The reaction rate (or -dSs/dt) is proportional to the normalized impedance change -d(|Z|/|Z0|)/dt and the 22 
surface density of phosphorylated substrate ΓSs is also proportional to |Z|/|Z0| with the same coefficient. 23 
As a result, the slope of -dSs/dt vs. ΓSs is the same as that of -d(|Z|/|Z0|)/dt vs. |Z|/|Z0|, and is equal to 24 
(kcat/Km)[E0], namely  25 
s
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 1 
(4) 2 
 3 
The value of kcat/Km is referred to as “specificity constant” which is commonly used to represent 4 
the catalytic efficiency of enzymes. The value of -d(|Z|/|Z0|)/dt of the modified REIS data can be 5 
calculated from the exponential fitting function |Z|/|Z0| = 0.944∙exp(-t/19.1) and plot vs. |Z|/|Z0| in Fig. 6B. 6 
Clearly, the curve can be fit with a straight line with a slope 0.0522 s
-1
. Since [E0]=2.4 nM is known, the 7 
specificity constant kcat/Km can be derived as 2.17 x 10
7
 M
-1
s
-1
. It is noteworthy that, despite the absolute 8 
impedance value |Z| varied in a large range on different NEA chips (from ~11,000 Ω to ~18,200 Ω in this 9 
study), the decay time constants derived from the normalized data (i.e. |Z|/|Z0|) are very similar at the 10 
same PTP1B concentration.  This is the critical quantity related to the enzyme activity. 11 
In order to rigorously determine the specificity constant kcat/Km, we investigated the 12 
dephosphorylation reactions at two lower PTP1B concentrations at 1.8, and 1.2 nM. The representative 13 
kinetic curves of the normalized |Z|/|Z0| at each PTP1B concentration are shown in Figs. S6A and S6C 14 
(Supplementary Information). Using the same method described above, the curves of -d(|Z|/|Z0|)/dt vs. 15 
|Z|/|Z0| can be derived and fit with straight lines as shown in Figs. S6B and S6D. Fig. 7A highlights three 16 
sets of data in 2.4, 1.8, and 1.2 nM PTP1B. A more comprehensive presentation containing 7 data sets 17 
was shown in Fig. S7 and summarized in Table 1. The slopes are clearly proportional to the enzyme 18 
concentration. The derived specificity constants kcat/Km are very close to each other with an average value 19 
at 2.13x10
7
 M
-1
s
-1
 and a standard deviation of 0.91x10
5
 M
-1
s
-1
. This value is consistent with the literature 20 
which lies between 1.1x10
6
 M
-1
s
-1
 for human PTP1B to 2.9x10
7
 M
-1
s
-1
 for rat PTP1 phosphatases [39, 40]. 21 
It is quite convincing that the electrochemical detection by REIS is a valid method for quantitative 22 
analyses of the PTP1B activity. 23 
 24 
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 1 
 2 
Fig. 7. Analyses of the enzymatic kinetics of the dephosphorylation process at three PTP1B concentrations. (A) The 3 
plot of –d(|Z|/|Z0|)/dt vs. |Z|/|Z0| fit with straight lines in 2.4 nM (■), 1.8 nM (▲), and 1.2 nM () PTP1B, 4 
respectively. (B) The slopes of –d(|Z|/|Z0|)/dt vs. |Z|/|Z0| derived from 7 data sets at three PTP1B concentrations, 5 
clearly showing a linear relationship with the PTP1B concentration. The catalytic efficiency, kcat/Km, was calculated 6 
to be 2.13 x 10
7
 M
-1
s
-1
 with a standard deviation of 9.1x10
5
 M
-1
s
-1
. 7 
 8 
In contrast to PTP1B, the reported specificity constant of c-Src kinase was two to three orders of 9 
magnitude lower, ranging from 2.4 x 10
3
 to 2.5 x 10
4
 M
-1
s
-1
 [35, 41-43]. This explains why we were not 10 
able to observe reliable kinetics with c-Src kinase. The small impedance change over much longer time 11 
can be easily overwhelmed by the baseline drift. For fast enzymatic reactions such as PTP1B 12 
21 
 
dephosphorylation, the potential of VACNF NEAs as a label-free electrochemical method can be fully 1 
utilized.  2 
Table 1 3 
Calculations of the catalytic efficiency kcat/KM of PTP1B dephosphorylation. 4 
Sample [PTP1B] 
(nM) 
Slope of  
-d(|Z|/|Z0|)/dt vs. |Z|/|Z0| 
(s
-1
) 
kcat/Km 
(x 10
7
 M
-1
s
-1
) 
1 2.43 0.0522 2.17 
2 2.43 0.0509 2.12 
3 2.43 0.0539 2.25 
4 1.82 0.0373 2.07 
5 1.82 0.0391 2.17 
6 1.22 0.0235 1.96 
7 1.22 0.0258 2.15 
Note: The statistical value of kcat/Km is (2.13 .091) x 10
7
 M
-1
s
-1
. 5 
 6 
4. Conclusions 7 
 8 
In summary, we have demonstrated the feasibility of a label-free electrochemical detection 9 
method for phosphorylation and dephosphorylation using peptide-functionalized VACNF NEAs by real-10 
time impedance measurements. A peptide sequence specific to c-Src tyrosine kinase and PTP1B 11 
phosphatase was designed and validated with ELISA based protein tyrosine kinase assay. The peptide 12 
was functionalized to the surface of VACNF NEAs. Reversible phosphorylation and dephosphorylation 13 
upon adding c-Src kinase and PTP1B into the electrochemical cell were observed. The dephosphorylation 14 
reaction by PTP1B showed well-defined fast kinetics in REIS measurements, which can be quantitatively 15 
analyzed using Michaelis-Menten heterogeneous enzymatic model. Reliable specificity constant kcat/Km 16 
for PTP1B can be derived. In contrast, the signal during phosphorylation was limited by the slow 17 
22 
 
enzymatic kinetics. These results indicate the potential of the electrochemical impedance method, 1 
particularly when applied on nanoelectrode arrays, as a viable label-free method for profiling enzyme 2 
activities in fast reactions of specific peptide substrates. 3 
 4 
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Supporting Information 9 
 10 
Fig. S1. Field-emission scanning electron micriscopic images of vertically aligned carbon nanofiber nanoelectrode 11 
arrays at 30° perspective view (A) and topview (B). The scale bars are 1 m. Note: This sample was over-etched 12 
with reactive ion etching (RIE) so that clearer images of the carbon nanofiber tip can be observed. 13 
 14 
B A 
26 
 
 1 
 2 
Fig. S2. The fluorescence image over the VACNF NEA chip showing streptavidin-labelled yellow-green fluorescent 3 
beads. The scale bar is 20 m. 4 
 5 
 6 
 7 
Fig. S3. The procedure of the ELISA assay to validate phosphorylation and dephosphorylation. The peptide 8 
substrates was first coated on the surface of 96-wellplate by incubating the peptide solution in the well at 37 °C 9 
overnight. After rinsing and dring at 37 °C for 2 hours, the solution containing c-Src kinase and ATP was added to 10 
the well and incubated for 30 minutes at room temperature. The wells were rinsed and refilled with the solution 11 
containing a horseradish peroxidase (HRP) linked phosphotyrosine monoclonal antibody and incubated for 30 12 
27 
 
minutes at room temperature. After rinsing off the unbound antibody, a freshly prepared o-phenylenediamine (OPD) 1 
solution was added. HRP catalyzed the conversion of colorless OPD into brown-color 2,3-diaminophenazine (DAP) 2 
which has strong molar absorptivity at 490 nm wavelength. The absorbance at 490 nm was finally read by a 3 
microplate reader. 4 
 5 
 6 
 7 
Fig. S4. The effects of K3Fe(CN)6/K4Fe(CN)6 mediators on the activity of c-Src kinase (61.7 kDa) in 8 
phosphorylation of biotinylated peptides by the ELISA assay. The squares (■) represent the measurements in the 9 
commercial tyrosine kinase buffer (500 mM HEPES, pH 7.4, 200 mM MgCl2, 1 mM MnCl2, and 2 mM Na3VO4) 10 
and the triangles (▲) are the results in the tyrosine kinase buffer after addition of 1 mM K3Fe(CN)6  and 1 mM 11 
K4Fe(CN)6. The concentration of ATP was fixed at 0.3 mM in all measurements. The absorbance at 490 nm 12 
corresponds to the amount of phosphorylated tyrosine, which is proportional to the concentration of c-Src kinase at 13 
the concentration varying from 0.18 nM to 5.9 nM (1.25-40 ng in 110 L). 14 
 15 
 16 
 17 
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Fig. S5. The effects of K3Fe(CN)6/K4Fe(CN)6 mediators and buffer composition on the activity of PTP1B 1 
phosphatase (37.4 kDa) by the ELISA assay. The buffer solutions are: (■) the commercial protein tyrosine 2 
phosphatase (PTP) buffer (50 mM HEPEs, pH 7.2, 1 mM EDTA, 1 mM DTT, and 0.05% NP-40); (▲) the 3 
commercial  PTP buffer plus 1 mM K3Fe(CN)6 and 1 mM K4Fe(CN)6; (●) the modified PTP buffer (with NP-40 4 
removed); and (♦) the modified PTP buffer plus 1 mM K3Fe(CN)6 and 1 mM K4Fe(CN)6. The plate was coated with 5 
the biotinylated peptide whose tyrosine residue was phosphorylated by incubating in 5.9 nM of c-Src kinase for 1 6 
hour before this experiment. The PTP1B phosphatase concentration was varied from 0.30 nM to 2.4 nM (1.25-10 ng 7 
in 110 L). Removal of the phosphate group from the phosphorylated tyrosine residue, i.e. dephosphorylation,  8 
caused the absorbance at 490 nm to drop. The decrease amplitude indicated the PTP1B activity. 9 
 10 
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 12 
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Fig. S6. Analyses of the enzymatic kinetics of the dephosphorylation in (A,B) 1.8 nM PTP1B (7.5 ng in 110 L 1 
solution) and (C,D)1.2 nM PTP1B (5.0 ng in 110 L solution). (A) The normalized real-time impedance data fit 2 
with an exponential function |Z|/|Z0| = 1.14∙exp (-t/26.6). (B) The curve of –d(|Z||Z0|)/dt vs. |Z|/|Z0| fit with a straight 3 
line giving a slope 0.0373 s
-1
. (C) The normalized real-time impedance data fit with an exponential function |Z|/|Z0| 4 
= 0.919∙exp (-t/38.5). (D) The curve of –d(|Z||Z0|)/dt vs. |Z|/|Z0| fit with a straight line giving a slope 0.0258 s
-1
. 5 
 6 
 7 
 8 
Fig. S7. Analyses of the enzymatic kinetics for the dephosphorylation at three different PTP1B concentrations: 2.4 9 
nM - Sample No. 1-3; 1.8 nM - Sample No. 4 and 5; 1.2 nM - Sample No. 6 and 7. The slope of –d(|Z|/|Z0|)/dt vs. 10 
|Z|/|Z0| is clearly proportional to the PTP1B concentration. 11 
